Gennova Biopharmaceuticals, which is working on India’s first mRNA Covid-19 vaccine, is in the midst of Phase-I trials of its Covid-19 vaccine (HGC019). Vikas Thapar, president – corporate development & strategy, Emcure Pharmaceuticals, said the Phase-I trials will be completed in the next 45-60 days. Phase-II trials will resume after that and take a similar time frame, he added.

Leave a Reply

Your email address will not be published. Required fields are marked *